Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats

BACKGROUND: Nanosilver is used in a variety of medical and consumer products because of its antibacterial activity. This wide application results in an increased human exposure. Knowledge on the systemic toxicity of nanosilver is, however, relatively scarce. In a previous study, the systemic toxicit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vandebriel, Rob J, Tonk, Elisa CM, de la Fonteyne-Blankestijn, Liset J, Gremmer, Eric R, Verharen, Henny W, van der Ven, Leo T, van Loveren, Henk, de Jong, Wim H
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4052812/
https://ncbi.nlm.nih.gov/pubmed/24885556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-8977-11-21
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars